dynaCERT_web_WBack Jan 2017.png
dynaCERT Announces Warrant Amendments
04 févr. 2019 16h30 HE | dynaCERT Inc.
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received approval from the...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Launches HydraGEN™ Technology for the Mining Industry
04 févr. 2019 07h00 HE | dynaCERT Inc.
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a new order for its...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Continues Innovation and Development of Intellectual Property Globally
31 janv. 2019 08h30 HE | dynaCERT Inc.
TORONTO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide an update on its numerous patents relating...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Appoints Mr. Frank Klees, Former Ontario Cabinet Minister, to Advisory Board
24 janv. 2019 08h30 HE | dynaCERT Inc.
TORONTO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the appointment of Mr. Frank Klees to the...
Equillium_Transparent-300px.png
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
19 déc. 2018 08h06 HE | Small Logo
LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...
download-2.png
Emerald Health Therapeutics Receives TSX Venture Conditional Approval of Emerald Health Naturals Joint Venture
19 nov. 2018 07h00 HE | Emerald Health Therapeutics Inc.
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Offers a Solution to 2019 European CO2 Regulations
24 sept. 2018 09h19 HE | dynaCERT Inc.
TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide an update on the TUV and homologation...
GG Logo_Vert-2.png
Galaxy Gaming Receives Key Approval in the State of Ohio
27 févr. 2018 14h29 HE | Galaxy Gaming, Inc.
LAS VEGAS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC:GLXZ), Galaxy Gaming is pleased to announce that it has received approval from the Ohio Casino Control Commission by a unanimous...
Jubilant DraxImage r
Jubilant DraxImage receives approval for new pulmonary indications from the U.S. Food and Drug Administration for DRAXIMAGE® DTPA
02 janv. 2018 10h45 HE | Jubilant DraxImage
Montreal, QC, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma wholly-owned subsidiary, is pleased to announce approval of new pulmonary indications for...
Jubilant DraxImage r
Jubilant DraxImage receives approval for 12-Hour shelf-life extension from the U.S. Food and Drug Administration for DRAXIMAGE® MAA
31 oct. 2017 08h45 HE | Jubilant DraxImage
Montreal, QC, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a wholly-owned subsidiary of Jubilant Pharma, is pleased to announce the U.S. Food and Drug Administration...